516 related articles for article (PubMed ID: 18547320)
1. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
Cavazzini F; Hernandez JA; Gozzetti A; Russo Rossi A; De Angeli C; Tiseo R; Bardi A; Tammiso E; Crupi R; Lenoci MP; Forconi F; Lauria F; Marasca R; Maffei R; Torelli G; Gonzalez M; Martin-Jimenez P; Maria Hernandez J; Rigolin GM; Cuneo A
Br J Haematol; 2008 Aug; 142(4):529-37. PubMed ID: 18547320
[TBL] [Abstract][Full Text] [Related]
2. Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients.
Cavazzini F; Rizzotto L; Sofritti O; Daghia G; Cibien F; Martinelli S; Ciccone M; Saccenti E; Dabusti M; Elkareem AA; Bardi A; Tammiso E; Cuneo A; Rigolin GM
Leuk Lymphoma; 2012 Jan; 53(1):83-8. PubMed ID: 21767243
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis.
Cuneo A; Rigolin GM; Bigoni R; De Angeli C; Veronese A; Cavazzini F; Bardi A; Roberti MG; Tammiso E; Agostini P; Ciccone M; Della Porta M; Tieghi A; Cavazzini L; Negrini M; Castoldi G
Leukemia; 2004 Mar; 18(3):476-83. PubMed ID: 14712287
[TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia FISH panel: impact on diagnosis.
Nelson BP; Gupta R; Dewald GW; Paternoster SF; Rosen ST; Peterson LC
Am J Clin Pathol; 2007 Aug; 128(2):323-32. PubMed ID: 17638669
[TBL] [Abstract][Full Text] [Related]
5. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin heavy chain (IGH@) translocations negatively impact treatment-free survival for chronic lymphocytic leukemia patients who have an isolated deletion 13q abnormality.
Gerrie AS; Bruyere H; Chan MJ; Dalal CB; Ramadan KM; Huang SJ; Toze CL; Gillan TL
Cancer Genet; 2012 Oct; 205(10):523-7. PubMed ID: 22939229
[TBL] [Abstract][Full Text] [Related]
7. Frequency of 5'IGH deletions in B-cell chronic lymphocytic leukemia.
Quintero-Rivera F; Nooraie F; Rao PN
Cancer Genet Cytogenet; 2009 Apr; 190(1):33-9. PubMed ID: 19264231
[TBL] [Abstract][Full Text] [Related]
8. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.
Reindl L; Bacher U; Dicker F; Alpermann T; Kern W; Schnittger S; Haferlach T; Haferlach C
Br J Haematol; 2010 Oct; 151(1):25-36. PubMed ID: 20649559
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel cryptic translocations involving IGH in B-cell non-Hodgkin's lymphomas.
Gozzetti A; Davis EM; Espinosa R; Fernald AA; Anastasi J; Le Beau MM
Cancer Res; 2002 Oct; 62(19):5523-7. PubMed ID: 12359763
[TBL] [Abstract][Full Text] [Related]
10. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
11. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
[TBL] [Abstract][Full Text] [Related]
12. Genomic aberrations and survival in chronic lymphocytic leukemia.
Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
[TBL] [Abstract][Full Text] [Related]
13. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
Lu G; Kong Y; Yue C
Cancer Genet Cytogenet; 2010 Jan; 196(1):56-63. PubMed ID: 19963136
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.
Kern W; Bacher U; Haferlach C; Dicker F; Alpermann T; Schnittger S; Haferlach T
Br J Haematol; 2012 Apr; 157(1):86-96. PubMed ID: 22224978
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
17. Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays.
Ciccone M; Agostinelli C; Rigolin GM; Piccaluga PP; Cavazzini F; Righi S; Sista MT; Sofritti O; Rizzotto L; Sabattini E; Fioritoni G; Falorio S; Stelitano C; Olivieri A; Attolico I; Brugiatelli M; Zinzani PL; Saccenti E; Capello D; Negrini M; Cuneo A; Pileri S
Leukemia; 2012 Mar; 26(3):499-508. PubMed ID: 21941366
[TBL] [Abstract][Full Text] [Related]
18. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH.
Parry-Jones N; Matutes E; Morilla R; Brito-Babapulle V; Wotherspoon A; Swansbury GJ; Catovsky D
Br J Haematol; 2007 Apr; 137(2):117-24. PubMed ID: 17391491
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel.
Reddy KS
Br J Haematol; 2006 Mar; 132(6):705-22. PubMed ID: 16487171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]